SARS-COV-2 as potential microRNA sponge in COVID-19 patients

被引:21
|
作者
Li, Chang [1 ,2 ]
Wang, Rebecca [3 ]
Wu, Aurora [4 ]
Yuan, Tina [5 ]
Song, Kevin [6 ]
Bai, Yongsheng [7 ,8 ]
Liu, Xiaoming [1 ,2 ]
机构
[1] Univ S Florida, USF Genom, Tampa, FL 33620 USA
[2] Univ S Florida, Coll Publ Hlth, Tampa, FL 33620 USA
[3] Pioneer High Sch, Ann Arbor, MI USA
[4] Emma Willard Sch, Troy, NY USA
[5] Roeper Sch, Birmingham, MI USA
[6] Credit Suisse, New York, NY USA
[7] Next Gen Intelligent Sci Training, Ann Arbor, MI USA
[8] Eastern Michigan Univ, Dept Biol, Ypsilanti, MI 48197 USA
关键词
MicroRNA; SARS-CoV-2; Viral infection; COVID-19; MicroRNA target; ACE2; CELL-CYCLE; PATHWAY;
D O I
10.1186/s12920-022-01243-7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background MicroRNAs (miRNAs) are a class of small non-coding RNA that can downregulate their targets by selectively binding to the 3 ' untranslated region (3 ' UTR) of most messenger RNAs (mRNAs) in the human genome. MiRNAs can interact with other molecules such as viruses and act as a mediator for viral infection. In this study, we examined whether, and to what extent, the SARS-CoV-2 virus can serve as a "sponge" for human miRNAs. Results We identified multiple potential miRNA/target pairs that may be disrupted during SARS-CoV-2 infection. Using miRNA expression profiles and RNA-seq from published studies, we further identified a highly confident list of 5 miRNA/target pairs that could be disrupted by the virus's miRNA sponge effect, namely hsa-miR-374a-5p/APOL6, hsa-let-7f-1-3p/EIF4A2, hsa-miR-374a-3p/PARP11, hsa-miR-548d-3p/PSMA2 and hsa-miR-23b-3p/ZNFX1 pairs. Using single-cell RNA-sequencing based data, we identified two important miRNAs, hsa-miR-302c-5p and hsa-miR-16-5p, to be potential virus targeting miRNAs across multiple cell types from bronchoalveolar lavage fluid samples. We further validated some of our findings using miRNA and gene enrichment analyses and the results confirmed with findings from previous studies that some of these identified miRNA/target pairs are involved in ACE2 receptor network, regulating pro-inflammatory cytokines and in immune cell maturation and differentiation. Conclusion Using publicly available databases and patient-related expression data, we found that acting as a "miRNA sponge" could be one explanation for SARS-CoV-2-mediated pathophysiological changes. This study provides a novel way of utilizing SARS-CoV-2 related data, with bioinformatics approaches, to help us better understand the etiology of the disease and its differential manifestation across individuals.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Clearance and persistence of SARS-CoV-2 RNA in patients with COVID-19
    Carmo, Analia
    Pereira-Vaz, Joao
    Mota, Vanda
    Mendes, Alexandra
    Morais, Celia
    da Silva, Andreia Coelho
    Camilo, Elisabete
    Pinto, Catarina Silva
    Cunha, Elizabete
    Pereira, Janet
    Coucelo, Margarida
    Martinho, Patricia
    Correia, Lurdes
    Marques, Gilberto
    Araujo, Lucilia
    Rodrigues, Fernando
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (10) : 2227 - 2231
  • [42] The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients
    Chen, Yifei
    Chen, Liangjun
    Deng, Qiaoling
    Zhang, Guqin
    Wu, Kaisong
    Ni, Lan
    Yang, Yibin
    Liu, Bing
    Wang, Wei
    Wei, Chaojie
    Yang, Jiong
    Ye, Guangming
    Cheng, Zhenshun
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (07) : 833 - 840
  • [43] SARS-CoV-2 is not found in the sweat of COVID-19 positive patients
    Bengi Arslan
    Sami Bercin
    Sibel Aydogan
    Yuce Islamoglu
    Bedia Dinc
    Irish Journal of Medical Science (1971 -), 2022, 191 : 27 - 29
  • [44] SARS-CoV-2 RNAemia and Disease Severity in COVID-19 Patients
    Lawrence Panchali, Merlin Jayalal
    Kim, Choon-Mee
    Seo, Jun-Won
    Kim, Da-Young
    Yun, Na-Ra
    Kim, Dong-Min
    VIRUSES-BASEL, 2023, 15 (07):
  • [45] Detection of antibodies against SARS-CoV-2 in patients with COVID-19
    Du, Zhe
    Zhu, Fengxue
    Guo, Fuzheng
    Yang, Bo
    Wang, Tianbing
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (10) : 1735 - 1738
  • [46] The Presence of SARS-CoV-2 in Conjunctival Secretions of COVID-19 Patients
    Ciloglu, Emine
    Dogan, Nese Cetin
    Ozdemir, Emre
    Kaya, Hatice
    Cetinkaya, Pelin Duru
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (04) : 652 - 655
  • [47] Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?
    Ali, Nurshad
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2020, 44 (04) : E84 - E86
  • [48] SARS-CoV-2 Is Present in Peritoneal Fluid in COVID-19 Patients
    Coccolini, Federico
    Tartaglia, Dario
    Puglisi, Adolfo
    Giordano, Cesira
    Pistello, Mauro
    Lodato, Marianna
    Chiarugi, Massimo
    ANNALS OF SURGERY, 2020, 272 (03) : E240 - E242
  • [49] Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19
    Kim, Min-Chul
    Cui, Chunguang
    Shin, Kyeong-Ryeol
    Bae, Joon-Yong
    Kweon, Oh-Joo
    Lee, Mi-Kyung
    Choi, Seong-Ho
    Jung, Sun-Young
    Park, Man-Seong
    Chung, Jin-Won
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (07): : 671 - +
  • [50] Presence of SARS-CoV-2 in plural effusion with COVID-19 patients
    Ataee, Zahra
    Hasanzadeh, Sepideh
    Mehri, Ali
    Sayadi, Mahdiyeh
    Ataei, Leila
    Jamehdar, Saeid Amel
    CLINICAL CASE REPORTS, 2021, 9 (05):